Metabolomics approach
Interpretation of changes in rat plasma metabolites after solifenacin treatment
DOI:
https://doi.org/10.1590/s2175-97902022e20849Keywords:
Solifenacin succinate, Metabolomics, Rat, LC-Q-TOF/MS/MSAbstract
Changes in metabolite levels of patients using the long-term drug can be comprehensively demonstrated by pharmacometabolomic studies. In this study, biological alterations induced by the administration of solifenacin succinate were investigated with a pharmacometabolomics approach on rat metabolism. Plasma samples obtained from rats were analyzed by LC-Q- TOF/MS/MS. METLIN and HMDB databases were used to identify metabolites. Data were processed and classified with MATLAB 2017b. 53 m/z values were found to be significantly different between the drug and control groups (p ≤ 0.01 and fold analysis > 1.5) and identified by comparing METLIN and HMDB databases. According to multivariate data analysis, changes in arachidonic acid, thromboxane A2, palmitic acid, choline, calcitriol, histamine phosphate, retinyl ester, l-cysteine, l-leucine, beta-alanine, l-histidine levels were found to be statistically significant compare to the control group. Differences in the biosynthesis of phenylalanine, aminoacyl-tRNA, tyrosine, tryptophan, metabolism of glycerophospholipid, cysteine, methionine, histidine, arachidonic metabolism have been successfully demonstrated by the metabolomics approach. Our study provides important information to explain the efficacy and toxicity of chronic administration of solifenacin succinate.
Downloads
References
Abrams P, Andersson KE, Buccafusco JJ, Chapple C, De Groat WC, Fryer AD, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148(5):565-78.
Ali M, Grogan S, Powell S, Staniford L, Nazir J, Landeira M, et al. Qualitative analysis of factors influencing patient persistence and adherence to prescribed overactive bladder medication in UK primary care. Adv Ther. 2019;36(11):3110- 22.
Amin AM, Chin LS, Teh CH, Mostafa H, Noor DAM, Kader MASA, et al. Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients. Eur J Pharm Sci. 2018;117:351-361.
Aragona P, Rania L, Micali A, Puzzolo D. Nutrition and dry eye. Curr Ophthalmol Rep. 2013;1(2):58-64.
Astellas Pharma U. Inc. Telavancin Package Insert. Deerfield, IL: Astellas Pharma US. 2009.
Azmitia EC. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull. 2001;56(5):413-24.
Basu M. Management of overactive bladder. Gynecol Obstet Reprod Med. 2019;30(1):1-5.
Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M, et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010;105(9):1276-82.
Chapple C, Rechberger T, Al-Shukri S, Meffan P, Everaert K, Huang M, et al. Randomized, double-blind placebo-and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int . 2004;93(3):303-10.
Chu F, Smith N, Uchida T. Efficacy and safety of solifenacin succinate 10 mg once daily: a multicenter, phase III, randomized, double-blind, placebo-controlled, parallel- group trial in patients with overactive bladder. Curr Ther Res Clin Exp. 2009;70(6):405-20.
Doroshyenko O, Fuhr U. Clinical pharmacokinetics and pharmacodynamics of solifenacin. Clin Pharmacokinet. 2009;48(5):281-302.
Drake MJ, Chapple C, Esen AA, Athanasiou S, Cambronero J, Mitcheson D, et al. Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week solifenacin monotherapy: a randomised double- blind multicentre phase 3B study (BESIDE). Eur Urol. 2016;70(1):136-45.
Finney SM, Andersson KE, Gillespie JI, Stewart LH. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int . 2006;98(3):503-7.
Girard CL, Matte JJ. Changes in serum concentrations of folates, pyridoxal, pyridoxal-5-phosphate and vitamin B12 during lactation of dairy cows fed dietary supplements of folic acid. Can J Anim Sci. 1999;79(1):107-114.
Gundogdu G, Miloglu FD, Senol O, Koza Y, Gundogdu F. Investigation of the metabolic difference between ST- elevated myocardial infarction and non-ST-elevated myocardial infarction via LC/Q-TOF/MS/MS. J Anal Sci Technol. 2019;10(1):31.
Gwynne RM, Ly KD, Parry LJ, Bornstein JC.Calcium sensing receptors mediate local inhibitory reflexes evoked by L-phenylalanine in Guinea pig jejunum. Front Physiol. 2017;(8):991.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;57(3):266- 281.
Hongpaisan J. Inhibition of proliferation of contaminating fibroblasts by D-valine in cultures of smooth muscle cells from human myometrium. Cell Biol Int. 2000;24(1):1-7.
Hutter R, Huang L, Speidl WS, Giannarelli C, Trubin P, Bauriedel G, et al. Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation. 2013;128(22):2351-2363.
Kim TH, Lee KS. Persistence and compliance with medication management in the treatment of overactive bladder. Investig Clin Urol. 2016;57(2):84-93.
Krhut J, Gärtner M, Petzel M, Sykora R, Nemec D, Tvrdik J, et al. Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients. Scand J Urol. 2014;48(1):79-83.
Kuligowski J, Sánchez-Illana Á, Sanjuán-Herráez D, Vento M, Quintás G. Intra-batch effect correction in liquid chromatography-mass spectrometry using quality control samples and support vector regression (QC-SVRC). Analyst. 2015;140(22):7810-7817.
Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2009;81(2-3):165-170.
Lee SH, Chung BH, Kim SJ, Kim JH, Kim JC, Lee JY. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study. Prostate Cancer Prostatic Dis. 2011;14(4):320-325.
Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92(1):4-8.
Lu F, Liu Y, Guo Y, Gao Y, Piao Y, Tan S, et al. Metabolomic changes of blood plasma associated with two phases of rat OIR. Exp Eye Res. 2020;190:107855.
Maman K, Aballea S, Nazir J, Desroziers K, Neine M-E, Siddiqui E, et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol . 2014;65(4):755-65.
Mamas M, Dunn WB, Neyses L, Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol. 2011;85(1):5-17.
Masunaga K, Yoshida M, Inadome A, Murakami S, Sugiyama Y, Satoji Y, et al. Pharmacological effects of solifenacin on human isolated urinary bladder. Pharmacology. 2008;82(1):43-52.
Mero A. Leucine supplementation and intensive training. Sports Med. 1999;27(6):347-358.
Ryan D, Robards K. Metabolomics: the greatest omics of them all? Anal Chem. 2006;78(23):7954-8.
Senol O, Gundogdu G, Gundogdu K, Miloglu FD. Investigation of the relationships between knee osteoarthritis and obesity via untargeted metabolomics analysis. Clin Rheumatol. 2019;38(5):1351-1360.
Shi L. Untargeted metabolomics and novel data analysis strategies to identify biomarkers of diet and type 2 diabetes. Uppsala: Acta Universitatis Agriculturae Sueciae, 1652-6880; 2017:108.
Shida T, Kondo E, Ueda Y, Takai N, Yoshida Y, Araki T, et al. Role of amino acids in salivation and the localization of their receptors in the rat salivary gland. Mol Brain Res. 1995;33(2):261-268.
Stark M, Lukaszuk J, Prawitz A, Salacinski A. Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training. J Int Soc Sports Nutr. 2012;9(1):54.
Sturtzel B, Dietrich A, Wagner KH, Gisinger C, Elmadfa I. The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber. J Nutr Health Aging. 2010;14(3):219-223.
Walpole SC, Prieto-Merino D, Edwards P, Cleland J, Stevens G, Roberts I. The weight of nations: an estimation of adult human biomass. BMC Public Health. 2012;12:439.
Yamaguchi O, Marui E, Kakizaki H, Itoh N, Yokota T, Okada H, et al. Randomized, double-blind, placebo-and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int . 2007;100(3):579-587.
Yildirim P, Garip Y, Karci AA, Guler T. Dry eye in vitamin D deficiency: more than an incidental association. Int J Rheum Dis. 2016;19(1):49-54.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
How to Cite
Funding data
-
Atatürk Üniversitesi
Grant numbers BAP-2019; Proje K: TDK-2019-7256
